Structural mechanisms for VMAT2 inhibition by tetrabenazine

被引：0
作者：
Dalton, Michael P. [1 ]
Cheng, Mary H. [2 ,3 ]
Bahar, Ivet [2 ,3 ]
Coleman, Jonathan [1 ]
机构：
[1] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA USA
[2] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY USA
[3] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY USA
来源：
BIOPHYSICAL JOURNAL | 2024年 / 123卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
625-Pos
引用
收藏
页码：116A / 116A
页数：1
相关论文
共 50 条
  • [41] Transcriptional regulation of the rat VMAT2 promoter by gastrin.
    Watson, F
    Kiernan, RS
    Deavall, DG
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A183 - A183
  • [42] Design and synthesis of vesicular monoamine transporter 2 (VMAT2) inhibitors
    Williams, John
    Harriott, Nicole
    Hoare, Sam
    Ashweek, Neil
    Pires, Jammieson
    Fan, Jun
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [43] Differential targeting of VMAT2 in neuronal and neuroendocrine cell lines
    Yao, DD
    Zhu, HM
    Ming, H
    Varoqui, H
    Erickson, J
    [J]. FASEB JOURNAL, 2001, 15 (04) : A551 - A551
  • [44] Real-World Experience with Novel VMAT2 Inhibitors
    Niemann, Nicki
    Jankovic, Joseph
    [J]. NEUROTHERAPEUTICS, 2018, 15 (04) : 1190 - 1191
  • [45] VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications
    Peckham, Alyssa M.
    Nicewonder, Jessica A.
    [J]. JOURNAL OF PHARMACY PRACTICE, 2019, 32 (04) : 450 - 457
  • [46] Lithium ions modulate the expression of VMAT2 in rat brain
    Cordeiro, ML
    Gundersen, CB
    Umbach, JA
    [J]. BRAIN RESEARCH, 2002, 953 (1-2) : 189 - 194
  • [47] ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease
    Seong Su Kang
    Eun Hee Ahn
    Xia Liu
    Matthew Bryson
    Gary W. Miller
    David Weinshenker
    Keqiang Ye
    [J]. Acta Neuropathologica, 2021, 142 : 139 - 158
  • [48] VMAT2 Inhibitors: New Drugs for the Treatment of Tardive Dyskinesia
    Kim, Anne P.
    Baker, Danial E.
    Levien, Terri L.
    [J]. CONSULTANT PHARMACIST, 2018, 33 (04): : 201 - 209
  • [49] VMAT2 and Parkinson's disease: harnessing the dopamine vesicle
    Lohr, Kelly M.
    Miller, Gary W.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (10) : 1115 - 1117
  • [50] ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease
    Kang, Seong Su
    Ahn, Eun Hee
    Liu, Xia
    Bryson, Matthew
    Miller, Gary W.
    Weinshenker, David
    Ye, Keqiang
    [J]. ACTA NEUROPATHOLOGICA, 2021, 142 (01) : 139 - 158
12345